Literature DB >> 1180059

Raising antibodies to human leukocyte interferon.

K E Mogensen, L Pyhälä, K Cantell.   

Abstract

Human leukocyte interferon proved to be a good immunogen in sheep, rabbits and guinea pigs. Sera from immunized animals neutralized the antiviral action of leukocyte interferon at high dilution. The highest anti-interferon titres obtained were 1:1,200,000 for sheep, 1:150,000 for rabbits, 1:30,000 for guinea pigs. Partial purification of human leukocyte interferon, by ethanol precipitation, improved its qualities as an immunogen. While it appeared more efficient to give initial injections without adjuvant, the inclusion in booster injections, of Freund's complete adjuvant produced a markedly superior response and, in one sheep, maintained high levels of circulating antibody for several months.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1180059     DOI: 10.1111/j.1699-0463.1975.tb00123.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  18 in total

1.  Human interferon: mass production in a newly established cell line, MG-63.

Authors:  A Billiau; V G Edy; H Heremans; J Van Damme; J Desmyter; J A Georgiades; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Stable and unstable forms of human fibroblast interferon.

Authors:  V G Edy; J Desmyter; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Infection of human peripheral blood mononuclear cells with a temperature-sensitive mutant of measles virus.

Authors:  S Vydelingum; J Ilonen; R Salonen; R Marusyk; A Salmi
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells.

Authors:  P Keskinen; T Ronni; S Matikainen; A Lehtonen; I Julkunen
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  Stimulated plasmacytoid dendritic cells impair human T-cell development.

Authors:  Heike Schmidlin; Wendy Dontje; Fedde Groot; Suzanne J Ligthart; Arnaud D Colantonio; Monique E Oud; Esther J Schilder-Tol; Marcel Spaargaren; Hergen Spits; Christel H Uittenbogaart; Bianca Blom
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

6.  Antigenic properties of human lymphoblastoid interferons.

Authors:  B J Dalton; K Paucker
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens.

Authors:  S E Starr; B Dalton; T Garrabrant; K Paucker; S A Plotkin
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

Review 8.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

9.  A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients.

Authors:  S Shiozawa; K Chihara; K Shiozawa; T Fujita; H Ikegami; S Koyama; M Kurimoto
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

10.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.